DTE vs FDMT
DTE (DTE) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
DTE currently screens at market cap $0. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the DTE and FDMT stock pages for the full models.
Not investment advice.